WAM Research Ltd. ( (AU:WAX) ) just unveiled an update.
Wilson Asset Management Group has become a substantial holder in Australian Clinical Labs Limited, acquiring a significant voting power of 5.83% through ordinary shares. This acquisition indicates a strategic move by Wilson Asset Management to increase its influence in the healthcare sector, potentially impacting the company’s future operations and market positioning.
More about WAM Research Ltd.
YTD Price Performance: 5.17%
Average Trading Volume: 142,304
Technical Sentiment Consensus Rating: Sell
For detailed information about WAX stock, go to TipRanks’ Stock Analysis page.